MarketPeel
Insider Trading Intelligence
BL

Bratton Capital Management, L.p.

DNLI
10% OWNER · DENALI THERAPEUTICS INC. · CIK 0001723787
FILING MIX · LIFETIME4%/96%
BUYS
1
SELLS
22
TOTAL VALUE
$17.48M
COMPANIES
2
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
47,051
AVG SELL PX
$30.68
TRADE KIND
SHOWING 23 / 23
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
15 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Bratton Capital Management, L.p., measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d15+26.67%+3.52%+0.79%+2.73%+3.46%
14d15+0.00%+5.34%+2.61%+2.73%+1.76%
30d15+73.33%-0.64%+5.32%-5.96%-7.12%
60d15+20.00%+23.20%+11.06%+12.14%+16.83%
90d15+20.00%+34.25%+8.01%+26.24%+37.92%
180d15+20.00%+202.22%+20.23%+181.98%+233.02%
1y15+20.00%+154.07%+37.85%+116.22%+169.48%
2y15+20.00%+0.65%+23.66%-23.01%-9.53%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
DNLI · 0 shares · as of Dec 21, 2020
0217,639435,277652,916870,554SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
FLOW · 1 buys / 22 sellsCOVERAGE · 4 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
AQST
AQUESTIVE THERAPEUTICS, INC.
SALE
524,6751,688,639Mar 12, 2021Mar 16, 2021
AQST
AQUESTIVE THERAPEUTICS, INC.
SALE
97,5982,657,943Mar 12, 2021Mar 16, 2021
AQST
AQUESTIVE THERAPEUTICS, INC.
SALE
564,1603,468,747Mar 12, 2021Mar 16, 2021
AQST
AQUESTIVE THERAPEUTICS, INC.
SALE
2,249,0770Mar 12, 2021Mar 16, 2021
AQST
AQUESTIVE THERAPEUTICS, INC.
PURCHASE
1,783,5781,948,578Mar 12, 2021Mar 16, 2021
AQST
AQUESTIVE THERAPEUTICS, INC.
SALE
40,40447,051Mar 12, 2021Mar 16, 2021
AQST
AQUESTIVE THERAPEUTICS, INC.
SALEGRANT
Gift
62,50012,585Mar 9, 2021Mar 16, 2021
DNLI
DENALI THERAPEUTICS INC.
SALE
383,4110Dec 21, 2020Dec 23, 2020
DNLI
DENALI THERAPEUTICS INC.
SALE
876$81.13$71.1K383,411Dec 14, 2020Dec 15, 2020
DNLI
DENALI THERAPEUTICS INC.
SALE
16,949$80.35$1.36M384,287Dec 14, 2020Dec 15, 2020
DNLI
DENALI THERAPEUTICS INC.
SALE
46,799$80.05$3.75M401,236Dec 11, 2020Dec 15, 2020
DNLI
DENALI THERAPEUTICS INC.
SALE
200$24.34$4.9K448,035Jun 30, 2020Jun 30, 2020
DNLI
DENALI THERAPEUTICS INC.
SALE
45,145$24.01$1.08M448,235Jun 30, 2020Jun 30, 2020
DNLI
DENALI THERAPEUTICS INC.
SALE
61,807$23.84$1.47M514,151Jun 29, 2020Jun 30, 2020
DNLI
DENALI THERAPEUTICS INC.
SALE
20,771$24.50$509.0K493,380Jun 29, 2020Jun 30, 2020
DNLI
DENALI THERAPEUTICS INC.
SALE
13,604$24.67$335.6K575,958Jun 26, 2020Jun 30, 2020
DNLI
DENALI THERAPEUTICS INC.
SALE
108,473$23.84$2.59M589,562Jun 26, 2020Jun 30, 2020
DNLI
DENALI THERAPEUTICS INC.
SALE
3,247$26.19$85.0K698,035Jun 23, 2020Jun 23, 2020
DNLI
DENALI THERAPEUTICS INC.
SALE
16,777$25.69$430.9K701,282Jun 23, 2020Jun 23, 2020
DNLI
DENALI THERAPEUTICS INC.
SALE
24,683$25.12$620.0K718,059Jun 22, 2020Jun 23, 2020
DNLI
DENALI THERAPEUTICS INC.
SALE
65,373$24.66$1.61M742,742Jun 22, 2020Jun 23, 2020
DNLI
DENALI THERAPEUTICS INC.
SALE
82,481$24.20$2.00M870,554Jun 19, 2020Jun 23, 2020
DNLI
DENALI THERAPEUTICS INC.
SALE
62,439$25.00$1.56M808,115Jun 19, 2020Jun 23, 2020
Other insiders · DNLI
Loading peer insiders…
About this filer
CIK 0001723787
ROLE
10% Owner
PRIMARY
DNLI
COMPANIES
2
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001723787DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback